Increase of RP105-1acking activated B cells in the peripheral blood and salivary glands in patients with Sjögren's syndrome

Clinical and Experimental Rheumatology

Volumn 26, Issue 1, 2008, Pages 5-12

  Kikuchi, Yuji ^a,d   Koarada, Syuichi ^a   Nakamura, Seiji ^b   Yonemitsu, Nobuhisa ^a   Tada, Yoshifumi ^a   Haruta, Yoshio ^a   Morito, Fumitaka ^a   Ohta, Akihide ^a   Miyake, Kensuke ^c   Horiuchi, Takahiko ^d   Nagasawa, Kohei ^a  

^a SAGA UNIVERSITY   (Japan)

^b KYUSHU UNIVERSITY   (Japan)

^c UNIVERSITY OF TOKYO   (Japan)

^d KYUSHU UNIVERSITY   (Japan)

Author keywords

Germinal center; RP105 negative B cells; Salivary glands; Sj gren's syndrome

Indexed keywords

IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; RP105 PROTEIN; TOLL LIKE RECEPTOR; UNCLASSIFIED DRUG; CD180 PROTEIN, HUMAN; LEUKOCYTE ANTIGEN;

ADULT; AGED; ARTICLE; B LYMPHOCYTE; BLOOD; CELL SELECTION; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FLOW CYTOMETRY; FROZEN SECTION; GERMINAL CENTER; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOGLOBULIN PRODUCTION; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; LYMPH FOLLICLE; LYMPHOCYTE ACTIVATION; LYMPHOCYTE COUNT; LYMPHOCYTE DIFFERENTIATION; LYMPHOCYTIC INFILTRATION; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SALIVARY GLAND; SALIVARY GLAND BIOPSY; SJOEGREN SYNDROME; SUPERNATANT; ADOLESCENT; CHEMISTRY; CYTOLOGY; MIDDLE AGED; PATHOLOGY; PHYSIOLOGY;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTIGENS, CD; B-LYMPHOCYTES; FEMALE; FLOW CYTOMETRY; HUMANS; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; LYMPHOCYTE ACTIVATION; LYMPHOCYTE COUNT; MALE; MIDDLE AGED; SALIVARY GLANDS; SJOGREN'S SYNDROME;

EID: 40749156675     PISSN: 0392856X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. BLOCH KJ, BUCHANAN WW, WOHL MJ, BUNIM JJ: Sjögren's syndrome: A clinical, pathological, and serological study of sixty-two cases. Medicine (Baltimore) 1965; 44: 187-231.
2. MOUTSOPOULOS HM, CHUSED TM, MANN DL et al.: Sjögren's syndrome (Sicca syndrome): Current issues. Ann Intern Med 1980; 92: 212-26.
3. HORSFALL AC, ROSE LM, MAINI RN: Auto-antibody synthesis in salivary glands of Sjögren's syndrome patients. J Autoimmun 1989; 2: 559-68.
4. HALSE AK, WAHREN-HERLENIUS M, JONSSON R: Ro/SS-A- and La/SS-B-reactive B lymphocytes in peripheral blood of patients with Sjödgren's syndrome. Clin Exp Immunol 1999; 115: 208-13.
5. XU KP, KATAGIRI S, TAKEUCHI T, TSUBOTA K: Biopsy of labial salivary glands and lacrimal glands in the diagnosis of Sjögren's syndrome. J Rheumatol 1996; 23: 76-82.
6. LANE HC, CALLIHAN TR, JAFFE ES, FAUCI AS, MOUTSOPOULOS HM: Presence of intracytoplasmic IgG in the lymphocytic infiltrates of the minor salivary glands of patients with primary Sjögren's syndrome. Clin Exp Rheumatol 1983; 1: 237-9.
7. DE WILDE PCM, KATER L, BAAK JPA, VAN HOUWELINGEN JC, HENÉ RJ. SLOOTWEG PJ: A new and highly sensitive immunohistologic diagnostic criterion for Sjögren's syndrome. Arthritis Rheum 1989; 32: 1214-20.
8. SPEIGHT PM, CRUCHLEY A, WILLIAMS DM: Quantification of plasma cells in labial salivary glands: Increased expression of IgM in Sjögren's syndrome. J Oral Pathol Med 1990; 19: 126-30.
9. TENGNÉR P, HALSE AK, HAGA HJ, JONSSON R, WAHREN-HERLENIUS M: Detection of anti-Ro/SSA and anti-La/SSB autoantibody-producing cells in salivary glands from patients with Sjögren syndrome. Arthritis Rheum 1998; 41: 2238-48.
10. SCOTT DI, HIEPE F, HUMMEL M, STEINHAUSER G, BEREK C: Antigen-driven clonal proliferation of B cells within the target tissue of an autoimmune disease. J Clin Invest 1998; 102: 938-46.
11. YOUINOU P, DARIDON C, SARAUX A, DEVAUCHELLE V, PERS JO: Is B-cell the conductor of the lymphocyte orchestra in the salivary glands of patients with primary Sjögren's syndrome. Clin Exp Rheumatol 2006; 24: 491-2.
12. ABBONDANZO SL: Extranodal marginal-zone B-cell lymphoma of the salivary gland. Ann Diagn Pathol 2001; 5: 246-54.
13. BAHLER DW, SWERDLOW SH: Clonal salivary gland infiltrates associated with myoepithelial sialadenitis (Sjögren's syndrome) begin as nonmalignant antigen-selected expansions. Blood 1998; 91: 1864-72.
14. MIYAKE K, YAMASHITA Y, HITOSHI Y, TAKATSU K, KIMOTO M: Murine B cell proliferation and protection from apoptosis with an antibody against a 105 kDa molecule: Unresponsiveness of X-linked immunodeficient B cells. J Exp Med 1994; 180: 1217-24.
15. MIYAKE K, YAMASHITA Y, OGATA M, SUDO T, KIMOTO M: RP105, a novel B cell surface molecule implicated in B cell activation, is a member of the leucine-rich repeat protein family. J. Immunol 1995; 154: 3333-40.
16. YAMASHITA Y, MIYAKE K, MIURA Y et al.: Activation mediated by RP105 but not CD40 makes normal B cells susceptible to anti-IgM-induced apoptosis: A role for Fc receptor coligation. J Exp Med 1996; 184: 113-20.
17. MIYAKE K, SHIMAZU K, KONDO J et al.: Mouse MD-1, a molecule that is physically associated with RP105 and positively regulates its expression. J Immunol 1998; 161: 1348-53.
18. OGATA H, SU I, MIYAKE K et al.: The Toll-like receptor protein RP105 regulates lipopolysaccharide signaling in B cells. J Exp Med 2000; 192: 23-9.
19. MIURA Y, MIYAKE K, YAMASHITA Y et al.: Molecular cloning of human RP105 homologue and chromosomal localization of the mouse and human RP105 genes (Ly64 and LY64). Genomics 1996; 38: 299-304.
20. FUGIER-VIVIER I, DE BOUTEILLER O, GURET C et al.: Molecular cloning of human RP105. Eur J Immunol 1997; 27: 1824-7.
21. MIURA Y, SHIMAZU R, MIYAKE K et al.: RP105 is associated with MD-1 and transmits an activation signal in human B cells. Blood 1998; 92: 2815-22.
22. KOARADA S, TADA Y, USHIYAMA O et al.: B cells lacking RP105, a novel B cell antigen, in systemic lupus erythematosus. Arthritis Rheum 1999; 42: 2593-600.
23. KIKUCHI Y, KOARADA S, TADA Y et al.: Difference in B cell activation between dermatomyositis and polymyositis: Analysis of the expression of RP105 on peripheral blood B cells. Ann Rheum Dis 2001; 60: 1137-40.
24. KOARADA S, TADA Y, KIKUCHI Y et al.: CD180 (RP105) in rheumatic diseases. Rheumatology (Oxford) 2001; 40: 1315-6.
25. KIKUCHI Y, KOARADA S, TADA Y et al.: RP105-lacking B cells from lupus patients are responsible for the production of immunoglobulins and autoantibodies. Arthritis Rheum 2002; 46: 3259-65.
26. VITALI C, BOMBARDIERI S, MOUTSOPOULOS HM et al.: Preliminary criteria for the classification of Sjögren's syndrome. Results of a prospective concerted action supported by the European Community. Arthritis Rheum 1993; 36: 340-7.
27. PASCUAL BV, LIU YJ, MAGALSKI A, DE BOUTEILLER O, BANCHEREAU J, CAPRA JD: Analysis of Somatic Mutation in Five B Cell Subsets of Human Tonsil. J Exp Med 1994; 180: 329-39.
28. BOHNHORST JO, BJORGAN MB, THOEN JE, NATVIG JB, THOMPSON KM: Bm1-Bm5 classification of peripheral blood B cells reveals circulating germinal center founder cells in healthy individuals and disturbance in the B cell subpopulations in patients with primary Sjögren's syndrome. J Immunol 2001; 167: 3610-8.
29. GROOM J, KALLED SL, CUTLER AH et al.: Association of BAFF/BLyS overexpression and altered B cell differentiation with Sjögren's syndrome. J Clin Invest 2002; 109: 59-68.